S
Shuhong Liu
Researcher at Chinese PLA General Hospital
Publications - 20
Citations - 7749
Shuhong Liu is an academic researcher from Chinese PLA General Hospital. The author has contributed to research in topics: Cirrhosis & Liver biopsy. The author has an hindex of 9, co-authored 17 publications receiving 5701 citations.
Papers
More filters
Journal ArticleDOI
Pathological findings of COVID-19 associated with acute respiratory distress syndrome.
Zhe Xu,Lei Shi,Yijin Wang,Ji-Yuan Zhang,Lei Huang,Chao Zhang,Shuhong Liu,Peng Zhao,Hongxia Liu,Li Zhu,Yanhong Tai,Changqing Bai,Tingting Gao,Jin-Wen Song,Peng Xia,Jing-Hui Dong,Jingmin Zhao,Fu-Sheng Wang +17 more
TL;DR: O surto do novo coronavÃrus (COVID-19) em Wuhan, China, iniciado em dezembro de 2019, evoluiu para se tornar uma pandemia global A.
Journal ArticleDOI
SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19.
Yijin Wang,Shuhong Liu,Hongyang Liu,Li Wei,Fang Lin,Lina Jiang,Xi Li,Pengfei Xu,Lixin Zhang,Lihua Zhao,Cao Yun,Jiarui Kang,Jianfa Yang,Ling Li,Xiaoyan Liu,Yan Li,Ruifang Nie,Jinsong Mu,Fengmin Lu,Shousong Zhao,Jiangyang Lu,Jingmin Zhao +21 more
TL;DR: The liver enzyme abnormality was associated with disease severity, as well as a series of laboratory tests including higher A-aDO2, higher GGT, lower albumin, decreased CD4+ T cells and B lymphocytes, and histologically, massive hepatic apoptosis and a certain binuclear hepatocytes were observed.
Journal ArticleDOI
Clinical and pathological investigation of patients with severe COVID-19.
Shaohua Li,Lina Jiang,Xi Li,Fang Lin,Yijin Wang,Boan Li,Tianjun Jiang,Weimin An,Shuhong Liu,Hongyang Liu,Pengfei Xu,Lihua Zhao,Lixin Zhang,Jinsong Mu,Hongwei Wang,Jiarui Kang,Yan Li,Lei Huang,Caizhong Zhu,Shousong Zhao,Jiangyang Lu,Junsheng Ji,Jingmin Zhao +22 more
TL;DR: Circulating cytokines, including IL-8, IL-6, TNF-α, IP10, MCP1, and RANTES, were significantly elevated in patients with severe COVID-19 and could be used to predict disease deterioration and inform clinical interventions.
Journal ArticleDOI
Serum Golgi protein 73 is not a suitable diagnostic marker for hepatocellular carcinoma.
Tianhui Liu,Mingjie Yao,Shuhong Liu,Lu Wang,Leijie Wang,Jinlin Hou,Xiong Ma,Jidong Jia,Jingmin Zhao,Hui Zhuang,Fengmin Lu +10 more
TL;DR: The receiver operating characteristic curve (ROC) analysis demonstrated that serum GP73 had poor performance for differentiating HCC patients from cirrhosis patients, and the immunohistochemistry revealed that aberrant expression of GP73 was primarily observed in cirrhotic and tumor liver tissues from both Cirrhosis and HCC Patients, but rarely in non-cirrhotic liver tissues.
Journal ArticleDOI
The Clinical Significance of GP73 in Immunologically Mediated Chronic Liver Diseases: Experimental Data and Literature Review
Mingjie Yao,Leijie Wang,Patrick S.C. Leung,Yanmei Li,Shuhong Liu,Lu Wang,Xiaodong Guo,Guangde Zhou,Ying Yan,Guiwen Guan,Xiangmei Chen,Christopher L. Bowlus,Tianhui Liu,Jidong Jia,M. Eric Gershwin,Xiong Ma,Jingmin Zhao,Fengmin Lu +17 more
TL;DR: Serum GP73 is an effective and reliable serological marker for the diagnosis of advanced fibrosis and prediction of appearance of cirrhosis in chronic liver diseases.